Overview

nContact Initiates US
Clinical Trials for the Treatment
of Atrial Fibrillation

Why Address Atrial Fibrillation (AF)?
Atrial Fibrillation (AF) is a type of arrhythmia. AF is characterized by very fast, irregular beating of the heart's upper chambers (the atria). AF increases the risk of stroke by fivefold, and can lead to the progression of heart disease. 

Open Chest Trial
nContact Inc. is conducting this trial to evaluate the safety and efficacy of the treatment of longstanding persistent AF using the investigational Numeris® - AF Tethered Coagulation System with VisiTrax® in patients scheduled for open heart surgery.  

Closed Chest Trials (studies active, but not recruiting participants)
nContact Inc. is evaluating the safety and efficacy of a combined epicardial (outer surface of heart tissue) /endocardial (inner surface of the heart tissue) beating heart ablation procedure without chest incisions or ports:

• For the treatment of symptomatic paroxysmal atrial fibrillation using the investigational Numeris® - AF Guided Coagulation System with VisiTrax® and the Biosense Webster® ThermoCool® Ablation Catheter
• For the treatment of longstanding persistent atrial fibrillation using the investigational Numeris® - AF Guided coagulation System with VisiTrax® and the St. Jude Medical Therapy® Cool Path® Ablation Catheter